` Comparison: 6BG vs ATXS - Alpha Spread

L
6BG
vs
ATXS

Over the past 12 months, 6BG has underperformed ATXS, delivering a return of -3% compared to the ATXS's +91 569% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
6BG
ATXS
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

L
6BG Intrinsic Value
0.006 EUR
Overvaluation 99%
Intrinsic Value
Price
ATXS Intrinsic Value
0.16 USD
Overvaluation 100%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
L
Lytix Biopharma AS
F:6BG
0.798 EUR
Astria Therapeutics Inc
NASDAQ:ATXS
5 784.3 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
6BG, ATXS

6BG
ATXS
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
L
Lytix Biopharma AS
Revenue
Astria Therapeutics Inc
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
6BG, ATXS

6BG
ATXS
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
L
Lytix Biopharma AS
F:6BG
Astria Therapeutics Inc
NASDAQ:ATXS
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

6BG
0%
ATXS
0%

Operating Margin

6BG
-12 206.9%
ATXS
-19 335.7%

Net Margin

6BG
-11 987.5%
ATXS
-17 568%

FCF Margin

6BG
-10 488%
ATXS
-17 042.9%

ROE

6BG
-97.8%
ATXS
-43.1%

ROA

6BG
-77.5%
ATXS
-39.2%

ROIC

6BG
-243.5%
ATXS
-462.1%

ROCE

6BG
-96.5%
ATXS
-45.9%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
6BG, ATXS

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
6BG, ATXS

Loading
6BG
ATXS
Difference
www.alphaspread.com

Performance By Year
6BG, ATXS

Loading
6BG
ATXS
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare 6BG to other stocks
PNEXF
Pharnext SCA
More expensive
vs 6BG
ABBV
Abbvie Inc
Cheaper
vs 6BG
AMGN
Amgen Inc
Cheaper
vs 6BG
GILD
Gilead Sciences Inc
Cheaper
vs 6BG
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett